Mylan Pharmaceuticals SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Mylan Pharmaceuticals analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Mylan Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Mylan Pharmaceuticals to benchmark its business & performance as compared to the competitors and industry. As of 2020, Mylan Pharmaceuticals is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Mylan Pharmaceuticals competitors and includes Mylan Pharmaceuticals target market, segmentation, positioning & Unique Selling Proposition (USP).

Mylan Pharmaceuticals SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Mylan Pharmaceuticals Brand Analysis
Parent Company

Mylan Pharmaceuticals




Pharma and Healthcare

Tagline/ Slogan

Seeing is believing


It is third largest generics manufacturing company in U.S

Mylan Pharmaceuticals STP
Mylan Pharmaceuticals Segmentation

API, nebulized respiratory or severe allergy medications & anti retroviral drugs

Mylan Pharmaceuticals Target Market

Healthcare professionals & doctors providing solutions in ART, respiratory diseases

Mylan Pharmaceuticals Positioning

Mylan is the company, which innovates to satisfy the unmet medical need & aims to provide 7 billion people of world medical solutions.

Mylan Pharmaceuticals SWOT Analysis
Mylan Pharmaceuticals Strengths

Below are the Strengths in the SWOT Analysis of Mylan Pharmaceuticals:

1. Mylan has strong generic portfolio with more than 1000 individual products

2. It has strong global presence in more than 150 countries

3. Their major strength is vertically integrated supply chain

4. Mylan has acquired generic business of Merck & Matrix pharmaceuticals which is largest generic Manufacturer in India

5. It has more than 15,000 well trained employees

Mylan Pharmaceuticals Weaknesses

Here are the weaknesses in the Mylan Pharmaceuticals SWOT Analysis:

1. Alleged litigations have sometimes impacted its public image

2. Very limited portion of its revenue comes from foreign business

Mylan Pharmaceuticals Opportunities

Following are the Opportunities in Mylan Pharmaceuticals SWOT Analysis:

1. Expiry of patent on Lipitor has open new business opportunities

2. Increasing awareness about healthcare

3. Increasing prevalence of chronic diseases such as cancer

Mylan Pharmaceuticals Threats

The threats in the SWOT Analysis of Mylan Pharmaceuticals are as mentioned:

1. Global economic slowdown

2. More stringent patent protection laws

3.Pending litigations

Mylan Pharmaceuticals Competition

Below are the top 4 Mylan Pharmaceuticals competitors:

1. Teva pharmaceuticals
2. Barr pharmaceuticals

3. Sandoz

4. Dr. Reddy’s laboratories

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Mylan Pharmaceuticals. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin